By Deena Beasley Oct 29 (Reuters) – Bristol Myers Squibb raised its full-year revenue forecast on Thursday, citing strong sales of its newer medicines, but lowered its 2026 earnings per share
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
(Corrects one-time in paragraph 2 to 58 cents from 60 cents) By Deena Beasley Oct…
By Nathan Vifflin and Fabrizio La Rocca Oct 29 (Reuters) - STMicroelectronics raised its 2026…
Oct 29 (Reuters) - Cerenome, Inc: * CERENOME COMPLETES ENROLLMENT IN PHASE 2 RESPECT-GBM TRIAL…
VIDEO SHOWS: ENGLAND STRIKER IVAN TONEY ARRIVING AND DEPARTING SOUTHWARK CROWN COURT / EXTERIORS OF…
By Manya Saini Oct 28 (Reuters) - Prediction markets are seeing massive trades for Anthropic…
By Manya Saini Oct 28 (Reuters) - Prediction markets are seeing massive trades for Anthropic…